Related Experiment Videos
[Drug interactions of tacrolimus]
Melanie E Sumner1, Stefanie Albers, Klaus G Schmidt
1Klinische Pharmazie und Pharmakotherapie, Heinrich-Heine-Universität Düsseldorf.
Medizinische Monatsschrift Fur Pharmazeuten
|April 25, 2006
Summary
Graft-versus-host disease (GvHD) after stem cell transplants requires immunosuppressants, increasing drug interaction risks. This case report details interactions between tacrolimus and other medications in a transplant patient.
Area of Science:
- Hematology and Immunology
- Pharmacology and Drug Interactions
Context:
- Allogeneic hematopoietic stem cell transplantation (HSCT) is a life-saving procedure.
- Graft-versus-host disease (GvHD) is a common and serious complication following HSCT.
- Immunosuppressive therapy is standard for managing GvHD, leading to polymedication.
Purpose:
- To discuss potential drug interactions in HSCT patients undergoing immunosuppression.
- To highlight the specific case of tacrolimus and its interactions with concomitant therapies.
Summary:
- GvHD necessitates immunosuppressants, often leading to polymedication in HSCT recipients.
- This case report examines drug interactions involving tacrolimus in a patient post-stem cell transplant.
- Understanding these interactions is crucial for managing patient safety and treatment efficacy.
Impact:
- Informs clinicians about potential adverse drug events in HSCT patients.
- Emphasizes the need for careful medication review and management in this vulnerable population.
- Contributes to safer patient care protocols for hematopoietic stem cell transplantation.